Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-17

Clinical Trial Update: Evaluation of the OtoBand in Subjects With Self-reported Vertigo to Reduce Severity of Vertigo in a Real-world Setting [NA]

View source ↗

Summary

A completed clinical trial evaluating the OtoBand device for reducing the severity of vertigo in individuals with vertigo in real-world settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OtoBand

Snippet

Sponsor: Otolith Labs | Conditions: Vertigo | NA | Status: COMPLETED